← Back to Discover
ACUTA CAPITAL PARTNERS, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $143,494,671
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $27,719,273
- WHITEHAWK THERAPEUTICS INC · COM · 00032Q104 · shares: $21,461,477
- TANGO THERAPEUTICS INC · COM · 87583X109 · shares: $12,221,066
- SUTRO BIOPHARMA INC · COM · 869367201 · shares: $8,972,333
- ARRIVENT BIOPHARMA INC · COM · 04272N102 · shares: $7,597,430
- 4D MOLECULAR THERAPEUTICS INC · COM · 35104E100 · shares: $6,753,753
- BRIGHT MINDS BIOSCIENCES INC · COM NEW · 10919W405 · shares: $6,510,699
- OCULAR THERAPEUTIX INC · COM · 67576A100 · shares: $5,228,963
- ERASCA INC · COM · 29479A108 · shares: $4,858,446
- SURROZEN INC · COM NEW · 86889P208 · shares: $4,499,600
Reported holdings
23 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 82,796 shares | $27,719,273 |
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | — | 4,685,912 shares | $21,461,477 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 390,949 shares | $12,221,066 |
| SUTRO BIOPHARMA INC | COM | 869367201 | — | 270,251 shares | $8,972,333 |
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | — | 218,694 shares | $7,597,430 |
| 4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | — | 507,801 shares | $6,753,753 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 92,745 shares | $6,510,699 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 532,481 shares | $5,228,963 |
| ERASCA INC | COM | 29479A108 | — | 265,199 shares | $4,858,446 |
| SURROZEN INC | COM NEW | 86889P208 | — | 173,395 shares | $4,499,600 |
| ARGEN SE - ADR | SPONSORED ADR | 04016X101 | — | 4,705 shares | $4,365,158 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS ORD A | 61559X104 | — | 215,652 shares | $4,198,744 |
| DESIGN THERAPEUTICS INC | COM | 25056L103 | — | 282,564 shares | $4,088,701 |
| MINERVA NEUROSCIENCES | COM NEW | 603380205 | — | 709,500 shares | $3,937,725 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 561,808 shares | $3,825,912 |
| AVALYN PHARMA INC | COM SHS | 05348Y105 | — | 115,000 shares | $3,785,800 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 186,308 shares | $3,442,972 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 168,115 shares | $3,019,345 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 260,416 shares | $2,526,035 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 595,213 shares | $1,303,516 |
| UNITED THERAPEUTICS CORP | COM | 91307C102 | — | 2,224 shares | $1,205,030 |
| CONTINEUM THERAPEUTICS INC-A | CL A | 21217B100 | — | 63,095 shares | $1,034,127 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 28,919 shares | $938,566 |